Observational studyBMC pharmacology & toxicology2017

Efficacy and safety of enzyme-replacement-therapy with agalsidase alfa in 36 treatment-naïve Fabry disease patients.

Kazuya Tsuboi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.